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Abstract
Background: Antibiotic resistance is a global public health threat. Water from human activities is collected at
wastewater treatment plants where processes often do not sufficiently neutralize antibiotic resistant bacteria and
genes, which are further shed into the local environment. This protocol outlines the steps to conduct a systematic
review based on the Population, Exposure, Comparator and Outcome (PECO) framework, aiming at answering the
question “Are antimicrobial-resistant enterobacteriaceae and antimicrobial resistance genes present (O) in air and
water samples (P) taken either near or downstream or downwind or down-gradient from wastewater treatment
plants (E), as compared to air and water samples taken either further away or upstream or upwind or up-gradient
from such wastewater treatment plant (C)?” Presence of antimicrobial-resistant bacteria and genes will be
quantitatively measured by extracting their prevalence or concentration, depending on the reviewed study.
Methods: We will search PubMed, EMBASE, the Cochrane database and Web of Science for original articles
published from 1 Jan 2000 to 3 Sep 2018 with language restriction. Articles will undergo a relevance and a design
screening process. Data from eligible articles will be extracted by two independent reviewers. Further, we will
perform a risk of bias assessment using a decision matrix. We will synthesize and present results in narrative and
tabular form and will perform a meta-analysis if heterogeneity of results allows it.
Discussion: Antibiotic resistance in environmental samples around wastewater treatment plants may pose a risk of
exposure to workers and nearby residents. Results from the systematic review outlined in this protocol will allow to
estimate the extend of exposure, to inform policy making and help to design future studies.
Keywords: Antibiotic resistance bacteria, Antibiotic resistance genes, Wastewater treatment plants, Environmental
samples, Systematic review protocol
Background
Antibiotic resistance has become an imminent global
public health threat and multiple studies have identified
resistant bacteria and resistance genes in environmental
samples [1, 2]. Water resulting from human activities
such as agriculture, healthcare services and from the
general population is collected at wastewater treatment
plants (WWTPs), turning them into unintentional collec-
tion points for antimicrobial drugs, antibiotic-resistant
bacteria (ARB) and resistance genes (ARG) [3]. Wastewa-
ter treatment processes are not designed to remove ARB
and ARG, so WWTPs typically harbor antimicrobials and
other agents known to co-select for antibiotic resistance
[4, 5]. These ARB and ARG present in the air and water in
and around WWTP may spread depending on proximity
to workers and nearby residents, and they are shed into
outgoing environmental systems such as rivers and reser-
voirs [1].
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This protocol describes the methodology that we will use
to evaluate presence of ARB and ARG from E. coli and
other enterobacteriaceae in air and water samples from
WWTPs and to find out especially if these levels are higher
in close proximity to WWTPs. To reduce a potential high
level of heterogeneity regarding the setting, the type of
samples, and the species and strains of bacteria and genes
[6, 7], our systematic review will focus specifically on an-
swering the following research question: Are antimicrobial-
resistant enterobacteriaceae and antimicrobial resistance
genes present (O) in air and water samples (P) taken either
near or downstream or downwind or down-gradient from a
wastewater treatment plant (E), as compared to air and
water samples taken either further away or upstream or up-
wind or up-gradient from such wastewater treatment plant
(C)? Presence of antimicrobial-resistant bacteria and genes
will be quantitatively measured by extracting their preva-
lence or concentration, depending on the reviewed study.
Review team roles and responsibilities
Information about the team members working in this
systematic review along with their applicable knowledge




This systematic review will be conducted following the
general steps outlined in Fig. 1, from writing the protocol
to extracting the data. We have constructed our research
question following the PECO framework (Table 2). Our
Population of interest is air and water samples from
WWTPs; our Exposure is locations near WWTPs, or
downstream/downwind/down-gradient from the WWTP
in a unidirectional system. Our Comparison group refers
to locations far away from the WWTPs, or upstream/up-
wind/up-gradient from the WWTP in a unidirectional
system. Our Outcome is the presence of antimicrobial-
resistant bacteria, especially E. coli and other coliforms,
and their resistance genes, measured by extracting either
their prevalence or concentration in the reported samples,
depending on the reviewed study. We expect to retrieve
mostly cross-sectional studies.
Although we hypothesize that the closer to a WWTP,
the higher the quantitative presence of ARB and ARG, a
cut-off point for this distance has not been established
for anthropogenic sources [8]. Therefore, “proximity”,
“close distance” and other similar terms will not be de-
fined for the purposes of this systematic review.
Sources of information
We will perform a thorough and rigorous search of the
current literature using several electronic databases, spe-
cifically PubMed, EMBASE, the Cochrane database and
Web of Science, including its sub-databases such as Bio-
sis Citation Index, Core Collection, Current Contents
Connect and Scielo. After having performed preliminary
searches, we have realized that before the year 2000
Table 1 Team members of the planned systematic review
Team member Applicable knowledge and skills Responsibilities
Daloha Rodriguez-Molina Epidemiologic methods, antibiotic resistance
epidemiology, microbiology, systematic review
and meta-analysis methods, clinical experience
with antibiotics, occupational and environmental
epidemiology
Create and describe literature research
method, study screening, data extraction,
evidence evaluation, content drafting and
approval, statistical analysis (if applicable)
Petra Mang Microbiology and epidemiology of antibiotic
resistance, systematic review methods, clinical
experience with antibiotics
Study screening, data extraction,
evidence evaluation
Heike Schmitt Microbiology of antibiotic resistance in the
environment, veterinary medicine, transmission
of resistant bacteria with surface water and
manure, WWTP expertise, human exposure to
antimicrobial resistant factors and carriage of
exposed populations, systematic review methods.
Systematic review methods consultation,
content review and approval
Mariana Carmen Chifiriuc Microbiology of antibiotic resistant bacteria and
resistance genes in the environment, human
exposure to antimicrobial resistant factors and
carriage of exposed populations.
Microbiology consultation, content review
and approval
Laura Wengenroth Epidemiologic methods, antibiotic resistance
epidemiology, systematic review and meta-analysis
methods, social sciences, occupational and
environmental epidemiology
Systematic review methods consultation,
content review and approval
Katja Radon Epidemiologic methods, systematic review and
meta-analysis methods, environmental engineering,
occupational and environmental epidemiology
Systematic review methods consultation,
content review and approval
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studies about antimicrobial resistance were mostly fo-
cused on the clinical setting and not on environmental
samples. We have therefore decided to look for all scien-
tific articles with full-texts published in English, German,
Spanish, Italian, Portuguese and French, from January 1,
2000 to September 3, 2018.
We will not perform hand-search of journals, confer-
ence proceedings, theses or dissertations, nor will we use
web search engines (e.g. Google Scholar) as these
methods are typically not precise enough, difficult to re-
produce and time consuming [9, 10].
Search strategy
Our search strategy for PubMed is the following:
((”drug resistance, microbial“[Mesh] AND”Escherichia
coli“[Mesh:NoExp] OR”Carbapenem-Resistant Enterobac-
teriaceae“[Mesh] OR”Enterobacter“[MAJR]) AND (”Water
Microbiology“[Mesh] OR ”Waste Water/microbiology“[-
MAJR] OR ”Air Microbiology“[Mesh]) AND (”humans“[-
MeSH Terms] OR ”waste water“[MeSH Terms] OR
”sewage“[MeSH Terms]) NOT Review[Publication Type])
Similar search strategies adapted to other databases
will be generated after this one and using the Systematic
Review Accelerator web tool [11].
Data management
Titles and abstracts of identified articles will be imported
into EndNote X8.2 (Thomson Reuters). The screening
Fig. 1 Steps of the systematic review process
Table 2 Eligibility criteria using the PECO framework
Population Air and water samples from WWTPs
Exposure Locations near WWTPs, or downstream/downwind/down-gradient from this plant in a unidirectional system
Comparator Locations far away from WWTPs, or upstream/upwind/up-gradient from this plant in a unidirectional system
Outcome Prevalence or concentration of ARB or ARG, specifically from E. coli and other coliforms
ARB antibiotic-resistant bacteria, ARG antibiotic resistance genes, WWTPs wastewater treatment plants
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process will be done using Rayyan QCRI, a web applica-
tion to review articles for a systematic review [12].
Screening, risk of bias assessment and data extraction
will be performed with the help of forms and relational
databases in Access 2016 (Microsoft Corporation, Red-
mond, WA, USA). Statistical analyses, if needed for a
meta-analysis of the reviewed literature, will be per-
formed using R for mac version 3.5.0 or higher [13].
Study selection
Relevance screening
The first stage in our systematic review will be the rele-
vance screening. The main objective of this stage is to
check if articles comply with the research question and
are eligible for further review. Two reviewers will inde-
pendently assess titles and abstracts of all retrieved arti-
cles. Consensus between reviewers will be required and
potential conflicts will be resolved in meetings every two
weeks during the relevance screening phase. If it is not
possible to achieve consensus between the two assigned
reviewers, a third reviewer from the team will be con-
sulted as a tie-breaker. This stage will be carried out
with the help of a standardized questionnaire based on
previous works [6, 7, 14] and refined for the purposes of
our review. This instrument and screening methods will
be pre-tested by taking a random sample of n = 30 re-
trieved abstracts. The main aim of the pre-test is to
make sure that there are no misunderstandings from the
reviewers regarding the use of the screening tool or the
user interface of the software used to track screening.
Our tool includes the following questions:
1. Does the abstract refer to primary research
reported in a journal publication or a thesis (as
opposed to a review article or presentation abstract
or proceedings)?
2. Were samples of water or air collected from the
exterior environment (i.e. not in a building or
internal facility)?
3. Were the samples collected from a WWTP as point
source?
4. Does the study measure either the prevalence or
the concentration of antibiotic resistance factors
(bacteria or genes) for enterobacteria in the
samples?
5. Does the study use microbial source tracking
techniques?
Possible answers to each one of these questions are
“Yes”, “No” and “It is not clear from the title and ab-
stract.” Based on our research question, we will consider
articles if they report findings from primary research,
collected environmental samples of air and water from a
WWTP and report the prevalence or concentration of
antibiotic resistance factors -either bacteria or genes-
from Enterobacteriaceae. Further, studies will be ex-
cluded if they used microbial source tracking techniques
because these techniques aim at identifying the source
of bacterial isolates or strains in environmental samples
and not at comparing the concentration or proportion
of resistant isolates in different locations [6, 7]. In other
words, studies will be included in our systematic review
if the answer to questions 1 to 4 is “yes” and to question
5 is “no”, and will be excluded if the answer to either of
the questions 1 through 4 is “no” or the answer to ques-
tion 5 is “yes”. If the title and abstract of the article do not
allow us to reach a clear yes/no answer to these questions,
we will classify the article as “unclear” and it will remain
available for discussion and further clarification.
Design screening
The next stage is the design screening. The main object-
ive of this stage is to check whether articles considered
proximity to a WWTP as an exposure variable, either by
comparing proximity to one or more comparison groups
or to a range of distances. We will also consider direc-
tion from the WWTP in a unidirectional system, e.g.
comparing downstream vs. upstream water samples in a
river system adjacent to a WWTP. We will additionally
check if the article is available in any of the following
languages: English, German, Spanish, Italian, Portuguese
or French.
In order to achieve the main aim of this stage, we will
retrieve the full-text document of publications remaining
after the relevance screening stage and read only the
methods section, omitting the results and conclusions
sections. We will use a standardized design screening
questionnaire containing the following questions:
6. Does the study implicitly or explicitly define a
WWTP as a point source with reference to which a
comparison was defined?
7. Does the study report proximity to or direction from
a WWTP?
8. Does the study specify a comparison group for the
samples? (e.g. samples taken upstream from the
source or at a fixed distance from the source)
9. Is the article written in English, German, Spanish,
Italian, Portuguese or French?
Articles will remain in our systematic review for further
data extraction and analysis if the answer to each of the
previous questions is “yes”. If the answer to any of the
questions is “no”, the article will be excluded without fur-
ther consideration. Decision conflicts and articles to which
the answer to any of the questions 1 to 3 is “unclear” will
be discussed by the two reviewers and inclusion will be
decided on a case-by-case basis. Articles that meet
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inclusion criteria after relevance and design screening will
be considered well-suited to answer our research question
and will continue onto the next stage, where we will ex-
tract the data and appraise the quality of each study.
Data extraction
Extracting relevant data from each study will facilitate
evidence synthesis, interpretation and presentation of re-
sults. Data will be independently extracted by the two
reviewers and inputted into a relational database struc-
tured form that will be pre-piloted with a sample con-
taining 10% of the citations eligible at this stage. A third
reviewer will be consulted for arbitration in case of
disagreements.
We will focus on these main categories for data ex-
traction: (a) type of sample, source and outcome, (b)
sample size, (c) statistical parameters in case modelling
was used, (d) confounding control and (e) measure of re-
sistance. Details on the specific values to extract for each
of these categories are given in Table 3.
Risk of bias assessment
We will identify threats to internal validity in each of the
remaining articles by performing a risk of bias assess-
ment based on previously published methods [14]. Be-
cause we are aiming at identifying threats to internal
validity, and not precision, quality or external validity,
we will not consider aspects such as statistical power,
representativeness, or adequate choice of statistical
methods. Statistical power is more related to precision
than to external validity [15], representativeness refers to
external validity, and adequate choice of statistical
methods is a measure of quality. For the purposes of our
review, we define quality as the best that the researchers
could have done under the specific circumstances of
their study, and not as whether there is a threat to in-
ternal validity. For example, in a randomized controlled
trial of surgery vs. a pharmaceutical gold standard for a
given health-related outcome, it is impossible to blind
researchers or participants. This study should still be
considered of high quality if the proposing treatment
(surgery) is the best candidate against the established
gold standard. However, this study will inevitable be at
risk of bias because it was not blinded.
For each publication, our risk of bias assessment will
be performed at the study design level and not at the
outcome level because we are interested in evaluating if
the techniques used in the included studies were suffi-
cient to avoid potential bias or if, on the contrary, bias
could have been introduced by design. At least two
reviewers will evaluate the risk of bias at each of these
domain levels: sample selection bias, information bias,
and confounding. Following an adaptation from the
Cochrane Collaboration Risk of Bias Tool [15], we will
Table 3 Data to be extracted from each study
Category Parameter to extract
Descriptive characteristics of the study • Location of the study
• Study design
Type of sample, source and outcome • Environmental media or biological sample type tested
• Location of the WWTP where the sample(s) was (were) taken
• Quantity of samples
• Bacterial species and/or genes analyzed
• Microbiological method used
Type of exposure • Categorical: Downstream, downwind or down-gradient
• Continuous: Distance to the WWTP; distance to the Comparator
Type of comparator • Categorical: Upstream, upwind or up-gradient
• Continuous: Distance to the WWTP; distance to the exposure site?
Sample size • If exposure is categorical: Sample size of each group
• If exposure is continuous: Total sample size
If statistical modelling was used • Type of model
• Effect measure (extracted or computed if there is enough raw data reported)
• Measure of variability
• p value
Confounding control • Methods to account for confounding or account for clustering data
Measure of resistance • Proportional: Is denominator present? Was the denominator stable across sampling sites?
• Absolute
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classify risk of bias to each domain as low, high or un-
clear. Further, we will determine the overall risk of bias
for each study as follows: if there is a low risk of bias in
all domains, the overall risk of bias will be low. If the risk
of bias is unclear in at least one of the three domains, the
overall risk of bias will be classified as unclear. Similarly, if
the risk of bias for one or more domains is high, the over-
all risk of bias will be considered high. An overall low risk
of bias means that plausible bias is not likely to change re-
sults, while an overall high risk of bias means that plaus-
ible bias may risk confidence in results. When the overall
risk of bias is unclear, it is accepted that there are some
doubts about the results.
Assessing risk of bias in each domain follows answer-
ing a specific question yes/no for each domain when
judging different study aspects or methodologies with
specific criteria. Criteria for the judgement of “yes”
translate into low risk of bias, and vice versa with criteria
for the judgement of “no”. Criteria will be judged as “un-
clear” if there is not enough information to reach a yes/
no answer. The specific question to be answered at each
domain level along with criteria for the judgement of
yes, no or unclear is shown in Table 4.
The risk of bias assessment procedure will be pre-
tested using a random sample of 10 % of the retrieved
articles until this point. The main aim of the pre-test is
to make sure that there are no misunderstandings from
the reviewers regarding the risk of bias assessment cri-
teria or the relational databases used to track this stage.
Evidence synthesis
We will report our results narratively and in tabular
form, presenting the information extracted from each of
the articles included in our review and our risk of bias
assessment. We will provide descriptive characteristics
of each of the studies (year, country, WWTP characteris-
tics if available, type of sample collected) and of their
outcomes (examined bacteria or genes, relevant com-
parison methods, relevant findings including effect mea-
sures), as well as our judgement for the risk of bias
assessment and the reason(s) for that given judgement.
If there is an enough number of high-quality studies
with a relatively low level of heterogeneity among effect
measures, we will pool findings into a fixed-effects or
random-effects meta-analysis and report these results
using forest and funnel plots.
Discussion
In this protocol, we have described our planned method-
ology to conduct a rigorous revision and synthesis of the
published literature regarding the prevalence or concen-
tration of antibiotic-resistant enterobacteria and resist-
ance genes in air and water samples around WWTPs.
Our pre-specified criteria for searching the literature,
screening relevant articles, assessing risk of bias and
extracting and presenting findings will guide us through
all of the steps of our review and help us avoid introdu-
cing bias a posteriori.
We can however anticipate some a priori sources of bias
for our review. Some studies only appear in conference
proceedings and do not reach a journal publication stage.
Excluding conference proceedings puts our review at risk
of containing publication bias. However, conference pro-
ceedings usually show only a short abstract of each study,
which does not allow proper screening or assessment, mak-
ing these procedures time-consuming and often leading to
fruitless results [10]. Further, hand-searching of journals,
conference proceedings and the use of web search engines
(e.g. Google scholar) is laborious, time-consuming, and
seldom improve the quality of systematic reviews [9]. We
expect our methods to ensure reproducibility while main-
taining appropriate levels of sensitivity and specificity. An-
other foreseeable source of bias comes from our language
restriction, which may introduce bias and lower precision.
However, previous meta-analyses on the impact of language
bias in systematic reviews and meta-analyses of controlled
trials have found that excluding trials published in lan-
guages other than English has a little effect on summary
treatment effect estimates [16, 17]. Therefore, by including
English and other Indo-European languages as a criterion
for inclusion, we minimize introducing language bias. An-
other strength of our methods is that, in order to ensure a
transparent and complete reporting, we will follow the Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA) [18]. A complete PRISMA checklist for
this protocol can be found in the Additional file 1.
To our knowledge, there are at least two previously
published systematic reviews with similar questions to
ours [6, 7]. These highly informative works present a
high level of study heterogeneity that prevented pooling
results. We believe that our systematic review will give
an update and will allow to draw more precise results fo-
cusing only on antibiotic-resistant enterobacteria and re-
sistance genes in air and water samples around WWTPs.
Further, we aim at widening our search of this more spe-
cific research question by using a different set of data-
bases, including EMBASE, the Cochrane database, Web
of Science and its sub-databases, thus providing a
broader understanding of the research question focused
on antibiotic-resistant enterobacteria and resistance
genes in air and water samples around WWTPs.
Although our planned systematic review is in the field
of environmental sciences, it is highly related to health-
related outcomes. Antibiotic-resistant enterobacteria and
resistance genes found in environmental samples around
WWTPs may pose a risk to the health status and well-
being of WWTP workers and nearby residents. Quantify-
ing the prevalence or concentration of antibiotic-resistant
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bacteria and genes in anthropogenic sources will improve
our understanding of the magnitude of the risk to which
humans are exposed. In addition, our study results will
provide guidance and support for planning future studies
and in the end to establish further requirements for the
usage of antimicrobial drugs, and for the treatment of
wastewater polluted with antibiotic-resistant bacteria and
resistance genes.
Table 4 Risk of bias assessment
Bias domain Assessment question Criteria
Sample selection bias Were sample locations and sampling methods
implemented such that sampling did not
introduce systematic differences depending
on the value of the exposure variable for each
sample (in the case of continuous exposure
data) or between the comparison groups
(in the case of categorical exposure measures)?
1. Criteria for the judgement of “Yes”:
• Method for determining the sampling locations
is identical independent of exposure status
(i.e. distance or direction from source);
• Restriction of sampling locations is applied in the
same way regardless of exposure status
(e.g. sampling sites are all agricultural fields with
a similar type and level of historical use);
• Time between sampling at all sites is sufficiently
close so as to render the outcomes measured at
these sites comparable for the sample type
in question
2. Criteria for the judgement of “No”:
• Sampling locations are selected differently;
• Restriction of sample locations is applied differently
depending on exposure status
3. Risk of bias will be considered “unclear” if there
is not enough information to judge sample selection
bias criteria as either “yes” or “no”, e.g. if methods
for determining sampling locations are not
described in enough detail
Information bias “Were outcome ascertainment methods
(i.e. methods of gene or bacterial
measurement) conducted in a way that
ensures the same accuracy regardless of
distance or direction from the source(s)?”
1. Criteria for the judgement of “Yes”:
• Identical microbiological methods applied to all
samples;
• Controlling for laboratory factors, if these are
different (e.g. which laboratory, technician, testing
date, instrument used);
• Blinding laboratory staff to exposure status
2. Criteria for the judgement of “No”:
• Application of different methods depending on
comparison group;
• No adjustment strategy for different laboratory
methods
3. Risk of bias will be considered “unclear” if there
is not enough information to judge information
bias criteria as either “yes” or “no”, e.g. if methods
for analyses are not explained sufficiently to reach
a judgement
Confoundinga “Were adequate methods to control for potential
confounding employed?”
1. Criteria for the judgement of “Yes”:
• Restriction of the sample population;
• Analytical confounding control (e.g. stratification,
regression adjustment)
2. Criteria for the judgement of “No”:
• Lack of any confounding control despite
confounding being likely;
• Inappropriate method of confounding control used;
• Controlling for confounding is correctly applied
for some potential confounders, but not for all
3. Risk of bias will be considered “unclear” if there
is not enough information to judge information bias
criteria as either “yes” or “no”, e.g. if methods to
control for confounding are mentioned but the
implementation is not explained sufficiently at length
to reach a judgement
aSome potential confounders for measuring antibiotic resistant bacteria and genes in environmental samples such as air and water samples include varying
bacterial population size across sampling locations, environmental media composition (e.g. water salinity), recent precipitation and other weather events, sample
composition and other sources of antibiotics or antibiotic resistance factors [18]
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